BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29430995)

  • 1. [
    Ooms M; Tsujikawa T; Lohith TG; Mabins SN; Zoghbi SS; Sumitomo A; Jaaro-Peled H; Kimura Y; Telu S; Pike VW; Tomoda T; Innis RB; Sawa A; Fujita M
    J Cereb Blood Flow Metab; 2019 Jul; 39(7):1306-1313. PubMed ID: 29430995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic interactions between PDE4B and GSK-3: DISC1 mutant mice.
    Lipina TV; Wang M; Liu F; Roder JC
    Neuropharmacology; 2012 Mar; 62(3):1252-62. PubMed ID: 21376063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Nonhuman Primate PET Study: Measurement of Brain PDE4 Occupancy by Roflumilast Using (R)-[
    Takano A; Uz T; Garcia-Segovia J; Tsai M; Lahu G; Amini N; Nakao R; Jia Z; Halldin C
    Mol Imaging Biol; 2018 Aug; 20(4):615-622. PubMed ID: 29441434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behaviour of [11C]R(-)- and [11C]S(+)-rolipram in vitro and in vivo, and their use as PET radiotracers for the quantificative assay of PDE4.
    Parker CA; Matthews JC; Gunn RN; Martarello L; Cunningham VJ; Dommett D; Knibb ST; Bender D; Jakobsen S; Brown J; Gee AD
    Synapse; 2005 Mar; 55(4):270-9. PubMed ID: 15668983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cAMP-dependent protein kinase activator and inhibitor on in vivo rolipram binding to phosphodiesterase 4 in conscious rats.
    Itoh T; Abe K; Hong J; Inoue O; Pike VW; Innis RB; Fujita M
    Synapse; 2010 Feb; 64(2):172-6. PubMed ID: 19852069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of brain phosphodiesterase type IV measured with 11C-(R)-rolipram positron emission tomography in major depressive disorder.
    Fujita M; Hines CS; Zoghbi SS; Mallinger AG; Dickstein LP; Liow JS; Zhang Y; Pike VW; Drevets WC; Innis RB; Zarate CA
    Biol Psychiatry; 2012 Oct; 72(7):548-54. PubMed ID: 22677471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET measurements of cAMP-mediated phosphodiesterase-4 with (R)-[11C]rolipram.
    Kenk M; Thomas A; Lortie M; Dekemp R; Beanlands RS; Dasilva JN
    Curr Radiopharm; 2011 Jan; 4(1):44-58. PubMed ID: 22191614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of human brain PDE4 occupancy by GSK356278: A [
    van der Aart J; Salinas C; Dimber R; Pampols-Maso S; Weekes AA; Tonkyn J; Gray FA; Passchier J; Gunn RN; Rabiner EA
    J Cereb Blood Flow Metab; 2018 Nov; 38(11):2033-2040. PubMed ID: 28737056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitotic activation of the DISC1-inducible cyclic AMP phosphodiesterase-4D9 (PDE4D9), through multi-site phosphorylation, influences cell cycle progression.
    Sheppard CL; Lee LC; Hill EV; Henderson DJ; Anthony DF; Houslay DM; Yalla KC; Cairns LS; Dunlop AJ; Baillie GS; Huston E; Houslay MD
    Cell Signal; 2014 Sep; 26(9):1958-74. PubMed ID: 24815749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET of (R)-11C-rolipram binding to phosphodiesterase-4 is reproducible and sensitive to increased norepinephrine in the rat heart.
    Thomas AJ; DaSilva JN; Lortie M; Renaud JM; Kenk M; Beanlands RS; deKemp RA
    J Nucl Med; 2011 Feb; 52(2):263-9. PubMed ID: 21270457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphodiesterase 4 inhibition enhances the dopamine D1 receptor/PKA/DARPP-32 signaling cascade in frontal cortex.
    Kuroiwa M; Snyder GL; Shuto T; Fukuda A; Yanagawa Y; Benavides DR; Nairn AC; Bibb JA; Greengard P; Nishi A
    Psychopharmacology (Berl); 2012 Feb; 219(4):1065-79. PubMed ID: 21833500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET measurement of the in vivo affinity of 11C-(R)-rolipram and the density of its target, phosphodiesterase-4, in the brains of conscious and anesthetized rats.
    Itoh T; Abe K; Zoghbi SS; Inoue O; Hong J; Imaizumi M; Pike VW; Innis RB; Fujita M
    J Nucl Med; 2009 May; 50(5):749-56. PubMed ID: 19372471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing synaptic noradrenaline, serotonin and histamine enhances in vivo binding of phosphodiesterase-4 inhibitor (R)-[11C]rolipram in rat brain, lung and heart.
    Lourenco CM; Kenk M; Beanlands RS; DaSilva JN
    Life Sci; 2006 Jun; 79(4):356-64. PubMed ID: 16499932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Powerful relaxation of phosphodiesterase type 4 inhibitor rolipram in the pig and human bladder neck.
    Ribeiro ASF; Fernandes VS; Martínez-Sáenz A; Martínez P; Barahona MV; Orensanz LM; Blaha I; Serrano-Margüello D; Bustamante S; Carballido J; García-Sacristán A; Prieto D; Hernández M
    J Sex Med; 2014 Apr; 11(4):930-941. PubMed ID: 24754330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo and in vitro measurement of brain phosphodiesterase 4 in rats after antidepressant administration.
    Fujita M; Imaizumi M; D'Sa C; Zoghbi SS; Crescenzo MS; Hong J; Musachio JL; Gee AD; Seidel J; Green MV; Pike VW; Duman RS; Innis RB
    Synapse; 2007 Feb; 61(2):78-86. PubMed ID: 17117418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and in vivo evaluation of a fluorine-18 rolipram analogue, [(18) F]MNI-617, as a radioligand for PDE4 imaging in mammalian brain.
    Thomae D; Morley TJ; Lee HS; Barret O; Constantinescu C; Papin C; Baldwin RM; Tamagnan GD; Alagille D
    J Labelled Comp Radiopharm; 2016 May; 59(5):205-13. PubMed ID: 27006107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET Imaging of Phosphodiesterase-4 Identifies Affected Dysplastic Bone in McCune-Albright Syndrome, a Genetic Mosaic Disorder.
    Weidner LD; Wakabayashi Y; Stolz LA; Collins MT; Guthrie L; Victorino M; Chung J; Miller W; Zoghbi SS; Pike VW; Fujita M; Innis RB; Boyce AM
    J Nucl Med; 2020 Nov; 61(11):1672-1677. PubMed ID: 32284396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a column-switching high-performance liquid chromatography method to assess the presence of specific binding of (R)- and (S)-[(11)C]rolipram and their labeled metabolites to the phosphodiesterase-4 enzyme in rat plasma and tissues.
    Kenk M; Greene M; Lortie M; Dekemp RA; Beanlands RS; Dasilva JN
    Nucl Med Biol; 2008 May; 35(4):515-21. PubMed ID: 18482689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of brain phosphodiesterase 4 in rat with (R)-[11C]Rolipram-PET.
    Fujita M; Zoghbi SS; Crescenzo MS; Hong J; Musachio JL; Lu JQ; Liow JS; Seneca N; Tipre DN; Cropley VL; Imaizumi M; Gee AD; Seidel J; Green MV; Pike VW; Innis RB
    Neuroimage; 2005 Jul; 26(4):1201-10. PubMed ID: 15961054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging cAMP-specific phosphodiesterase-4 in human brain with R-[11C]rolipram and positron emission tomography.
    DaSilva JN; Lourenco CM; Meyer JH; Hussey D; Potter WZ; Houle S
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1680-3. PubMed ID: 12458404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.